[PDF][PDF] Dual management: diabetes and sickle cell anemia in patient care
The coexistence of diabetes mellitus (DM) and sickle cell anemia (SCA) presents a complex
medical challenge, necessitating an integrated approach to patient care. This review …
medical challenge, necessitating an integrated approach to patient care. This review …
A Narrative Review of Effects of Poor Glycemic Control among Type 2 Diabetes Mellitus Patients
Cardiovascular complications were the main consequence of poor glycemic control. The
hospital management system needs to make sure that there are opportunities and times set …
hospital management system needs to make sure that there are opportunities and times set …
[PDF][PDF] Improving outcomes: integrated strategies for diabetes and sickle cell anemia
The coexistence of diabetes and sickle cell anemia poses a unique and complex healthcare
challenge, necessitating integrated strategies for improved outcomes. This review explores …
challenge, necessitating integrated strategies for improved outcomes. This review explores …
[PDF][PDF] Drug-drug interactions in the management of coexisting sickle cell anemia and diabetes
This review scrutinizes the intricate landscape of drug-drug interactions in the management
of coexisting sickle cell anemia and diabetes, two chronic conditions that often intersect …
of coexisting sickle cell anemia and diabetes, two chronic conditions that often intersect …
[PDF][PDF] Synergistic care approaches: integrating diabetes and sickle cell anemia management
Diabetes mellitus and sickle cell anemia are both complex and chronic conditions that pose
significant challenges to healthcare providers and individuals alike. The coexistence of …
significant challenges to healthcare providers and individuals alike. The coexistence of …
[PDF][PDF] Coexisting conditions: addressing diabetes in sickle cell anemia care
The coexistence of diabetes mellitus and sickle cell anemia presents a challenging clinical
scenario that necessitates a comprehensive and tailored approach to patient care. This …
scenario that necessitates a comprehensive and tailored approach to patient care. This …
[PDF][PDF] Immune Checkpoint Inhibitors in Type 1 Diabetes: A New Frontier in Therapy
Abstract Type 1 Diabetes (T1D) is a chronic autoimmune disease characterized by the
immune-mediated destruction of insulin-producing beta cells in the pancreas. Current …
immune-mediated destruction of insulin-producing beta cells in the pancreas. Current …
[PDF][PDF] Influence of Glycaemic Control and Microvascular Complications on Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study in Kano …
Increase in oxidative stress accelerates the risk of cardiovascular events in diabetes mellitus
(DM) by inducing inflammatory reactions and endothelial dysfunction This research was …
(DM) by inducing inflammatory reactions and endothelial dysfunction This research was …
[PDF][PDF] Gestational Diabetes and Neutrophil Activation: A Cellular Symphony
Gestational diabetes mellitus (GDM) represents a complex metabolic disorder during
pregnancy, impacting both maternal and fetal health. Recent investigations have shed light …
pregnancy, impacting both maternal and fetal health. Recent investigations have shed light …
[PDF][PDF] Receptor for Advanced Glycation-end Product and Related End Products of Glycation as Biochemical Markers for Microvascular Complications in Patients with …
AAJ BunzaJM, GMY SaniMU… - Elite Journal of …, 2024 - researchgate.net
Persistent hyperglycaemia causes advanced-glycation end products (AGEs) formation with
implication in the pathogenesis of microvascular complications in diabetes mellitus (DM) …
implication in the pathogenesis of microvascular complications in diabetes mellitus (DM) …